The Latest Breaking News from HAE

Despite an uncertain macroeconomic environment, the medical sector should remain robust due to inelastic demand. Therefore, investors could consider adding medical stocks Medtronic (MDT), Smith & Nephew (SNN), and Haemonetics (HAE), which look poised to grow, to their watchlists. Keep reading.

The healthcare sector often fares well during difficult times due to the constant need for its goods and services. Therefore, quality medical stocks Novo Nordisk (NVO), AmerisourceBergen (ABC), Cardinal Health (CAH), and Haemonetics (HAE) might be the best investments for investors’ portfolios given current macroeconomic headwinds. Read on….

Earlier this week, Raymond James attended Haemonetics Corp's (NYSE:HAE) Investor Day, where the management team presented a new Long-Range Plan (LRP), including some upside on the profitability, outlining each business unit's positioning and pipeline.  According to the analysts, the plan implies an upside to expectations, despite some conservatism and back-end weight. Raymond James rolled…

Haemonetics Corporation's (NYSE: HAE) analyst day later this month may include an update on its businesses, new products, margin outlook, and financial targets for FY24-FY26.